ArticleScientific reports2025

Real-world study of first-line immunotherapy combined with chemoradiotherapy in esophageal squamous cell carcinoma.

Xiaohan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.